
$55.3B+3% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $55.3B in 2025, compounding -4% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $59.2B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
$2.5B−9% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $2.5B in 2025, compounding -7% a year over three years. Trailing twelve-month profit stands at $2.5B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
+3.2%revenue growth, FY 2025
Off the axis: 2012 earnings -278.8% - rebounds off a collapsed prior year.
→Revenue grew +3% in 2025 against a five-year average of -0%. Earnings went the other way (-9%) even as sales grew, so margins compressed: costs rose faster than revenue. 2012's swing into loss (-279%) sits off the axis.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
$2.8B−11% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow was $2.8B in 2025, compounding -9% a year since 2022. The trailing twelve months stand at $3.9B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→Of $55.3B in 2025 sales, $2.5B reaches net profit - 5 cents on the dollar. The largest single deduction is producing the product ($43.9B).
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→5 cents of every sales dollar became free cash in 2025, and it has held steady since 2022 - its weakest conversion on record.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year
→The biggest claim on each sales dollar is research and development, at 3% of revenue (capital spending 2%, stock compensation 1%).
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→Operating profit outgrew revenue in only 2 of the last 5 years. Costs are growing roughly in step with the business, so scale isn't yet paying for itself.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year
→Operating margin has held near 6% since 2022. After everything, 5 cents of each sales dollar reaches net profit.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year
→Return on capital needs both a profit and an equity base; one of them isn't available here.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
12.7xP/E today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 12.7x earnings, the market is paying +61% more than HPQ's own 10-year median of 7.9x. Expectations are elevated, so more has to go right to justify the price. Today's multiple is the highest in the charted history.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
13.2%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys 13.2% of annual free cash flow, less than its 10-year median of 14.8% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
◌ 2026 = the latest balance sheet (2026-07-31), not a fiscal year-end
→Debt of $9.2B sits against $4.2B of cash. Earnings cover the interest bill 8 times over, so the debt is comfortably serviced.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→Shareholders' equity is negative at $-92M: liabilities exceed assets. Usually the mark of heavy buybacks or accumulated losses, and always worth understanding which.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→Shareholders received $850M in buybacks and $1.1B in dividends in 2025. Stock compensation issued $522M of new shares in the same year, offsetting 27% of that.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→The share count shrank 3.6% in 2025, averaging 3.2% a year over three years. Buybacks are concentrating your ownership: the same business, split fewer ways.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→The dividend per share reached $1.14 in 2025, compounding +10% a year since 2020.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
◌ 2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year
→The dividend consumed 43% of profit and 39% of free cash flow in 2025. That leaves room to keep paying through a weak year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→HPQ earns 25.9% on the capital it employs, well above the 10% most investors treat as the cost of capital. It was 41.1% in 2022, so the trend is down, though the path has been bumpy.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→HPQ has shrunk its share count -55% from 2011 to 2025, so each remaining share owns more of the business. Revenue per share is -3% over the same years.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31
→Insiders sold $5M on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 22 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-07-31